The "Fair drug pricing" conference will focus on the current trends in pricing and reimbursement in the high-price segment of innovative medicinal products in Germany ahead of the September general election.
Representatives of HTA body G-BA, pharma, payers, medical experts and MPs will discuss pricing and reimbursement models in the European context as well as data generation and data use in drug development and routine care. The conference is the major spring event organised by Forum-Institut für Management.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Health Europe.
